11 May 2021 : Original article
Surgical Outcome of Pulmonary Metastasectomy for Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
Yong Ho Jeong1ABCDEFG, Shin Hwang2ACDEF, Geun Dong Lee1AB, Se Hoon Choi1AB, Hyeong Ryul Kim1AB, Yong-Hee Kim1AB, Seung-Il Park1AB, Dong Kwan Kim1ABCDEFG*DOI: 10.12659/AOT.930383
Ann Transplant 2021; 26:e930383
Table 1 Clinicopathological characteristics of the 52 patients who underwent pulmonary metastasectomy for lung metastases after liver transplantation for hepatocellular carcinoma.
| Parameter | Value |
|---|---|
| Age, mean±SD (range), year | 56.0±6.6 (~37–69) |
| Male/Female | 46 (88.5%)/6 (11.5%) |
| Living-donor LT | 41 (78.8%) |
| Deceased-donor LT | 11 (21.2%) |
| 1.88±2.18 (0.90, ~0.04–8.48) | |
| ~0–1 yr | 28 (53.8%) |
| >~1–2 yrs | 7 (13.5%) |
| >2 yrs | 17 (32.7%) |
| ~1–10 | 21 (40.4%) |
| >~10–20 | 25 (48.1%) |
| >20 | 6 (11.5%) (up to 35 mm) |
| Single | 34 (65.4%) |
| Multiple (range, median) | 18 (34.6%) (~2–7, 3) |
| Wedge resection | 50 (96.2%) |
| Open | 4 (7.7%) |
| VATS | 46 (88.5%) |
| Lobectomy | 2 (3.8%) |
| Open | 1 (1.9%) |
| VATS | 1 (1.9%) |
| Normal (0–10 ng/mL) | 34 (65.4%) |
| Elevated (>10 ng/mL) | 18 (34.6%) |
| 3 (~2–22) | |
| Postoperative complication | |
| Persistent air leak (>7 days) | 4 (7.7%) |
| Yes | 33 (63.5%) |
| No | 19 (36.5%) |
| AFP – alpha-fetoprotein; LT – liver transplantation; PM – pulmonary metastasis; VATS – video-assisted thoracoscopic surgery. Results reported as n (%), unless otherwise indicated. | |